Expansion of Manufacturing Facilities for Additives Used in Lithium-Ion Secondary Batteries
First written in FY2017-Q3. 3 of 8 entries say "Advanced", first in FY2019-Q2. Latest entry: 2026-05-14.
Stella Chemifa moved to the "Worse" side of this theme in 2023.
The whole theme swung hardest in 2020: 2 of 14 companies on the "Worse" side.
0 other companies' latest entry also says "Mitigated".
- 2026-05-14MitigatedEarnings
「Impairment loss 190 —」
The impairment loss on additive production facilities and other assets recognized in the previous fiscal year was not recognized in the current fiscal year. - FY2025WorsenedAnnual report
「During the consolidated fiscal year, among the increased-production facilities for additives used in lithium-ion secondary batteries in the high-purity chemicals business, the Company decided to treat assets that had been expected to be repurposed as idle assets because they were not expected to be used in the foreseeable future. It reduced their carrying amounts to recoverable amounts and recognized the reduction as an impairment loss under extraordinary losses.」
Among the additive facilities developed for increased production, assets scheduled for repurposing were not expected to be used in the foreseeable future, and the Company recognized an impairment loss of ¥190 million. - FY2024-Q3WorsenedAnnual report
「Following consideration of the current market environment and production conditions for existing production facilities for additives used in lithium-ion secondary batteries in the High-Purity Chemicals segment, the Company determined that the prospects for their operation in the foreseeable future had declined substantially and decided to treat them as idle assets. During the cumulative third quarter of the consolidated fiscal year, it recognized ¥426 million as an impairment loss under extraordinary losses.」
As the prospects for operating the existing additive production facilities declined substantially in the foreseeable future, following the expansion of facilities intended for increased production, the Company recognized an impairment loss of ¥426 million. - FY2023-Q3WorsenedAnnual report
「Following a review of future business plans for additives used in lithium-ion secondary batteries in the High-Purity Chemicals segment, the Company determined that the future usability of manufacturing facilities held for increased production had declined. Accordingly, excluding assets that can be repurposed, it reduced their carrying amounts to recoverable amounts and recognized the reduction as an impairment loss under extraordinary losses. The impairment loss recognized during the cumulative third quarter of the consolidated fiscal year was ¥1,926 million.」
The Company reviewed its business plan for manufacturing facilities for additives used in lithium-ion secondary batteries that had been intended for increased production, and recognized an impairment loss of ¥1,926 million due to the decline in their future usability. - FY2020AdvancedAnnual report
「Spending on purchases of property, plant and equipment resulted from continued capital investment from the previous consolidated fiscal year, including renewal of production equipment in the semiconductor and liquid-crystal division of the high-purity chemicals business, expansion of facilities for additives used in lithium-ion secondary batteries, and purchases of containers and other items for transporting products in the transportation business.」
The Company continued capital investment including expansion of facilities for additives used in lithium-ion secondary batteries, and spending on purchases of property, plant and equipment through investing activities was ¥4,547 million. - FY2020-Q2AdvancedAnnual report
「Purchases of property, plant and equipment included the purchase of containers for transporting products, renewal of production equipment in the semiconductor and liquid-crystal division, and expansion of production facilities for additives used in lithium-ion secondary batteries.」
The Company acquired property, plant and equipment, including expanded production facilities for additives used in lithium-ion secondary batteries, and spending on acquisitions during the fiscal year was ¥2,733 million. - FY2019-Q2AdvancedAnnual report
「Cash used in investing activities was ¥1,854 million, an increase of ¥327 million in spending from the same period of the previous year. The main component was ¥1,683 million in purchases of property, plant and equipment. Purchases of property, plant and equipment reflected capital investment to accommodate increased shipment volumes, including the purchase of containers for transporting products, the renewal of production equipment in the semiconductor and liquid-crystal division, and the expansion of facilities for additives used in lithium-ion secondary batteries.」
The Company specifically states that it carried out capital investment including the expansion of facilities for additives used in lithium-ion secondary batteries. The purchase of containers and renewal of production equipment in the semiconductor and liquid-crystal division are also cited as measures to accommodate increased shipment volumes. - FY2017-Q3First statedAnnual report
「① Expansion of manufacturing facilities for additives used in lithium-ion secondary batteries」
The Company specifies for the first time a plan to expand manufacturing facilities for additives used in lithium-ion secondary batteries as a use of funds raised through bonds with share acquisition rights.